Mouthwash reformulation delays US launch
The US launch of the hotly touted, next-generation mouthwash, Decapinol, has stalled following the decision to reformulate the US product as a "precautionary measure".
Archives for August 13, 2007
Solvay kicks off peracetic acid production in China
Solvay's first Chinese plant for a key chemical disinfectant is now fully operational, serving the growing Chinese market and spreading the international chemical group's global reach ever further.
Weekly Comment
No lack of innovation in pharma, says Wyeth
The often cited decline in R&D productivity and dwindling innovation within the pharma industry is actually a thing of the past, according to Wyeth's head of business development.
US-Russian CRO pact inked
Russian contract research organisation (CRO) Synergy Research Group has hooked up with a US-based CRO in a bid to expand its services to North America.
First 3D images of living cell a 'dream'
A US scientist says he has fulfilled his dream by creating the first 3D images of a living cell, finally allowing researchers to study them in their natural state.
Pharma tops most IP-intensive list
The pharmaceutical industry has come up top in the most Intellectual Property (IP)-intensive industry in the US, according to a report released this week.
Drug delivery keeps eye on the market
A new drug delivery technology is looking promising as it gets its first glimpse of the US market with the launch of the eye drop AzaSite.
eClinical news brief
Outsourcing-Pharma tracks the latest eClinical movements, featuring Perceptive Informatics, Almac Clinical Technologies, Aptuit, INC Research and OmniComm Systems.
Antibody rival drawing investors to Molecular Partners
An award-winning therapeutic protein technology, touted as superior to antibodies, has attracted venture capitalist investment for its owners, the Swiss biotech Molecular Partners.